UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Journal of hepatology, 2019-05, Vol.70 (5), p.1019-1023

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

PloS one, 2022-06, Vol.17 (6), p.e0264741-e0264741

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of antiviral therapy for HCV on lipid levels

Antiviral therapy, 2017, Vol.21 (1), p.81-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

World journal of gastroenterology : WJG, 2014-08, Vol.20 (31), p.10984-10993

2014

Link zum Volltext

Verfügbarkeit prüfen

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Biomedicines, 2021-10, Vol.9 (10), p.1495

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-02, Vol.26 (2), p.205-210

2020

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

World journal of gastroenterology : WJG, 2012-03, Vol.18 (12), p.1339-1347

Claus Niederau Dietrich Huppe EImar Zehnter Bernd Moiler, Renate Heyne Stefan Christensen Rainer Waft Arno Theilmeier Ulrich Alshuth Stefan Mauss

2012

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S125-S128

2013

Link zum Volltext

Verfügbarkeit prüfen

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients

Antiviral therapy, 2008-01, Vol.13 (8), p.1091-1095

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

The New England journal of medicine, 2015-12, Vol.373 (27), p.2599-2607

2015

Link zum Volltext

Verfügbarkeit prüfen

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2021, Vol.64 (5), p.625-634

2021

Link zum Volltext

Verfügbarkeit prüfen

Prescription of new HCV-drugs - what has to be considered judicially

Zeitschrift fur Gastroenterologie, 2015-01, Vol.53 (1), p.43

Mauss, Stefan

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Clinical infectious diseases, 2013, Vol.57

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1405-1411

2016

Link zum Volltext

Verfügbarkeit prüfen

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Clinical infectious diseases, 2020-08, Vol.71 (5), p.1248-1254

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68 (4), p.663-671

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapy of HIV-HBV-coinfection

MMW Fortschritte der Medizin, 2009-04, Vol.151 (18), p.49

Mauss, Stefan

2009

Link zum Volltext

Verfügbarkeit prüfen

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Journal of hepatology, 2022-07, Vol.77, p.S562-S563

2022

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Clinical infectious diseases, 2016-11, Vol.63 (10), p.1320-1324

2016

Link zum Volltext

Verfügbarkeit prüfen

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e607-e612

2023

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

Journal of hepatology, 2022-07, Vol.77, p.S16

2022

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl 2), p.S129-S137

2013

Link zum Volltext

Verfügbarkeit prüfen

Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis

The Journal of infectious diseases, 2019-10, Vol.220 (10), p.1635-1644

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(97)
Deutsch
(14)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Humans
(63)
Life Sciences & Biomedicine
(63)
Male
(41)
Adult
(37)
Infectious Diseases
(37)
Female
(36)
Middle Aged
(34)
Antiviral Agents - Therapeutic Use
(30)
Aged
(18)
Biological And Medical Sciences
(18)
Hepatitis C, Chronic - Drug Therapy
(18)
Hiv
(18)
Hiv Infections - Drug Therapy
(18)
Microbiology
(18)
Treatment Outcome
(18)
Gastroenterology & Hepatology
(17)
Human Immunodeficiency Virus
(17)
Immunology
(17)
Drug Therapy, Combination
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+ T Regulatory Cells Correlates with Progressive Disease

Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry

Effect of antiviral therapy for HCV on lipid levels

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R)

Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Prescription of new HCV-drugs - what has to be considered judicially

Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs: Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward

Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Therapy of HIV-HBV-coinfection

Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R)

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study)

Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA)

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis

Aktive Filter

Suchergebnisse filtern